{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T17:09:19Z","timestamp":1783876159772,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","strokejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Stroke and Cerebrovascular Diseases"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106905","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T03:45:04Z","timestamp":1670211904000},"page":"106905","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Changing trends and factors influencing anticoagulant use in patients with acute ischemic stroke and NVAF at discharge in the NOACs era"],"prefix":"10.1016","volume":"32","author":[{"given":"Sufang","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0001","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.amjcard.2018.05.015","article-title":"The disease burden of atrial fibrillation in China from a national cross-sectional survey","volume":"122","author":"Wang","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022478","article-title":"Risk factors for thrombo-embolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational Prevention of thromboembolic events-European Registry in Atrial Fibrillation (PREFER in AF)","volume":"9","author":"Rohla","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0003","doi-asserted-by":"crossref","first-page":"h3786","DOI":"10.1136\/bmj.h3786","article-title":"Real-world effectiveness of warfarin among ischemic stroke patients with atrial fibrillation: observational analysis from patient-centered research into outcomes stroke patients prefer and effectiveness research (PROSPER) study","volume":"351","author":"Xian","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0004","first-page":"846","article-title":"Chinese subgroup analysis of the global anticoagulant registry in the FIELD (GARFIELD) registry in the patients with non-valvular atrial fibrillation","volume":"42","author":"Sun","year":"2014","journal-title":"Zhong hua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/STROKEAHA.115.011833","article-title":"Use of warfarin at discharge among acute ischemic stroke patients with nonvalvular atrial fibrillation in China","volume":"47","author":"Yang","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0006","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"38","key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0007","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0008","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.joa.2017.05.004","article-title":"2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation","volume":"33","author":"Chiang","year":"2017","journal-title":"J Arrhythm"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0009","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.chest.2018.07.040","article-title":"Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report","volume":"154","author":"Lip","year":"2018","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0011","first-page":"125","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0012","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.CCM.0000050446.16158.80","article-title":"Treatment of space-occupying cerebral infarction","volume":"31","author":"Hofmeijer","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0013","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0014","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.jacc.2017.09.1085","article-title":"2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American college of cardiology task force on expert consensus decision pathways","volume":"70","author":"Tomaselli","year":"2017","journal-title":"J Am Coll Cardio"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0015","doi-asserted-by":"crossref","first-page":"e1627","DOI":"10.1097\/MD.0000000000001627","article-title":"Do NOACs improve antithrombotic therapy in secondary stroke prevention in nonvalvular atrial fibrillation?","volume":"94","author":"Lin","year":"2015","journal-title":"Medicine"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0016","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0140-6736(93)92358-Z","article-title":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group","volume":"342","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0017","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2006-01-010645","article-title":"Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions","volume":"109","author":"Undas","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0018","first-page":"761","article-title":"Role of antiplatelet therapy in stroke prevention in patients with atrial fibrillation [J]","volume":"117","author":"Manaktala","year":"2017","journal-title":"J AM Osteopath Assoc"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0019","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1212\/01.wnl.0000267275.68538.8d","article-title":"Independent predictors of stroke in patients with atrial fibrillation: a systematic review","volume":"69","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0021","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10557-020-06981-3","article-title":"Anticoagulants for stroke prevention in atrial fibrillation in elderly patients","volume":"34","author":"Sch\u00e4fer","year":"2020","journal-title":"J Cardiovasc Drugs Ther"},{"issue":"5","key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0022","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.chest.2019.11.025","article-title":"Comparing the effectiveness and safety of nonvitamin K antagonist oral anticoagulants and warfarin in elderly asian patients with atrial fibrillation: a nationwide cohort study[J]","volume":"157","author":"Chao","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0023","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clineuro.2007.03.009","article-title":"Atherothrombotic ischemic stroke in patients with atrial fibrillation","volume":"109","author":"Benbir","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0024","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000047740","article-title":"Carotid artery stenosis in ischemic stroke patients with nonvalvular atrial fibrillation","volume":"13","author":"Chang","year":"2002","journal-title":"Cerebrovascular Dis"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0025","doi-asserted-by":"crossref","first-page":"720","DOI":"10.5551\/jat.43240","article-title":"Clinical and imaging characteristics of cerebral infarction in patients with nonvalvular atrial fibrillation combined with cerebral artery stenosis","volume":"25","author":"Sun","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0026","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.amjmed.2014.03.026","article-title":"Coexistence of intracranial atherosclerosis and nonvalvular atrial fibrillation","volume":"127","author":"Jolobe","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0027","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomized controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0028","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s12975-020-00822-z","article-title":"Effectiveness of adding antiplatelets to oral anticoagulants in patients with acute ischemic stroke with atrial fibrillation and concomitant large artery steno-occlusion","volume":"11","author":"Kim","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0029","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1161\/STROKEAHA.120.032232","article-title":"Atherosclerotic burden and vascular risk in stroke patients with atrial fibrillation","volume":"52","author":"Park","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0030","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1080\/01616412.2016.1187864","article-title":"Frequency and risk factors of spontaneous hemorrhagic transformation following ischemic stroke on the initial brain CT or MRI: data from the China National Stroke Registry (CNSR)","volume":"38","author":"Chen","year":"2016","journal-title":"Neurol Res"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0031","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00415-014-7297-8","article-title":"Frequency and predictors of spontaneous hemorrhagic transformation in ischemic stroke and its association with prognosis","volume":"261","author":"Tan","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0032","doi-asserted-by":"crossref","first-page":"e89798","DOI":"10.1371\/journal.pone.0089798","article-title":"Use of antithrombotics after hemorrhagic transformation in acute ischemic stroke","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0033","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010133","article-title":"Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: time to initiation of oral anticoagulant therapy and outcomes","volume":"7","author":"Paciaroni","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0034","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1161\/01.STR.0000254600.92975.1f","article-title":"Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials","volume":"38","author":"Paciaroni","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0035","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","article-title":"Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study","volume":"46","author":"Paciaroni","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.jstrokecerebrovasdis.2022.106905_bib0036","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1161\/STROKEAHA.120.028867","article-title":"Anticoagulation type and early recurrence in cardioembolic stroke: the IAC study","volume":"51","author":"Yaghi","year":"2020","journal-title":"Stroke"}],"container-title":["Journal of Stroke and Cerebrovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305722005973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052305722005973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:56:46Z","timestamp":1760943406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052305722005973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1052305722005973"],"URL":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2022.106905","relation":{},"ISSN":["1052-3057"],"issn-type":[{"value":"1052-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing trends and factors influencing anticoagulant use in patients with acute ischemic stroke and NVAF at discharge in the NOACs era","name":"articletitle","label":"Article Title"},{"value":"Journal of Stroke and Cerebrovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2022.106905","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106905"}}